Moleculin Biotech, Inc.
MBRX
$7.59
$0.9614.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.87M | 8.90M | 8.87M | 8.79M | 8.88M |
| Depreciation & Amortization | 112.00K | 122.00K | 125.00K | 126.00K | 130.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.21M | 25.44M | 25.91M | 26.64M | 28.92M |
| Operating Income | -24.21M | -25.44M | -25.91M | -26.64M | -28.92M |
| Income Before Tax | -50.99M | -32.62M | -22.81M | -21.35M | -29.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -50.99 | -32.62 | -22.81 | -21.35 | -29.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -50.99M | -32.62M | -22.81M | -21.35M | -29.73M |
| EBIT | -24.21M | -25.44M | -25.91M | -26.64M | -28.92M |
| EBITDA | -24.10M | -25.32M | -25.78M | -26.52M | -28.79M |
| EPS Basic | -70.86 | -101.11 | -147.01 | -180.17 | -298.02 |
| Normalized Basic EPS | -44.29 | -63.20 | -91.88 | -112.61 | -186.26 |
| EPS Diluted | -70.86 | -101.11 | -147.01 | -180.17 | -298.02 |
| Normalized Diluted EPS | -44.29 | -63.20 | -91.88 | -112.61 | -186.26 |
| Average Basic Shares Outstanding | 2.70M | 1.36M | 826.10K | 550.90K | 430.00K |
| Average Diluted Shares Outstanding | 2.70M | 1.36M | 826.10K | 550.90K | 430.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |